Commentary on: Three-Dimensional Arterial Distribution Over the Midline of the Nasal Bone

Wu, Woffles

doi:10.1093/asj/sjac095

Cited by 2 publications

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, there is a high degree of interpatient variability in the location of blood vessels in the nose, and other safety measures must therefore be adopted. [18][19][20][21] I favor the use of aspiration.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Nonsurgical rhinoplasty using the hyaluronic acid filler VYC‐25L: Safety and patient satisfaction in a retrospective analysis of 492 patients

Jalali

2023

J of Cosmetic Dermatology

View full text Add to dashboard Cite

BackgroundAesthetic treatment of the nose with hyaluronic acid (HA) fillers is increasingly popular but carries a small risk of major complications. Large patient cohorts are required to better understand this risk.AimsTo evaluate safety and patient satisfaction in a large series of nonsurgical rhinoplasty treatments with the HA filler, VYC‐25L, in “real world” clinical practice.MethodsThis was a retrospective analysis of consecutive adult patients undergoing nonsurgical rhinoplasty with VYC‐25L by a single injector between January 2020 and July 2022. All patients received initial treatment (typically ~0.3–0.5 mL of filler) and touch‐up at 4–6 weeks (~0.1–0.3 mL). Safety data were collected throughout a mean follow‐up of 11.1 months. Patient satisfaction was assessed using the FACE‐Q Satisfaction with Nose and Satisfaction with Outcome questionnaires.ResultsA total of 492 patients were included (984 treatment sessions including touch‐ups). Of these, 467 (94.9%) were female and the mean age was 30.0 years. All treatments were associated with early transient edema; other adverse events included bruising (n = 123; 25%), residual asymmetry (n = 18; 3.7%), and suspected localized vascular occlusion (n = 3; 0.6%). The latter cases were easily resolved with hyaluronidase injection plus oral steroid and aspirin. No patients experienced infection, necrosis, blindness, lumps, granuloma, or delayed‐onset nodules. Mean Rasch‐transformed FACE‐Q scores were 90.2% for Satisfaction with Nose and 99.2% for Satisfaction with Outcome.ConclusionsIn a large cohort of patients treated in routine practice based on a systematic approach, nonsurgical rhinoplasty with VYC‐25L was safe and effective.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Injections should be made deep and into the midline where possible, as this may reduce the probability of intravascular injection. However, there is a high degree of interpatient variability in the location of blood vessels in the nose, and other safety measures must therefore be adopted 18–21 . I favor the use of aspiration.…”

Section: Discussionmentioning

confidence: 99%

Nonsurgical rhinoplasty using the hyaluronic acid filler VYC‐25L: Safety and patient satisfaction in a retrospective analysis of 492 patients

Jalali

2023

J of Cosmetic Dermatology

View full text Add to dashboard Cite

show abstract

Commentary on: Three-Dimensional Arterial Distribution Over the Midline of the Nasal Bone

Cited by 2 publications

References 9 publications

Nonsurgical rhinoplasty using the hyaluronic acid filler VYC‐25L: Safety and patient satisfaction in a retrospective analysis of 492 patients

Nonsurgical rhinoplasty using the hyaluronic acid filler VYC‐25L: Safety and patient satisfaction in a retrospective analysis of 492 patients

Commentary on: A Computed Tomographic Investigation of the Ophthalmic Artery Volume and its Relevance to Soft Tissue Filler Injection

Contact Info

Product

Resources

About